- Home
- OPAL vs IMA Comparison
OPAL vs IMA Comparison
Compare OPAL & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPAL | IMA |
|---|---|---|
| Founded | 1998 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 65.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OPAL | IMA |
|---|---|---|
| Price | $2.17 | $7.07 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 4 | 2 |
| Target Price | $2.81 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 242.0K | 36.8K |
| Earning Date | 03-12-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $329,243,000.00 | $800,000.00 |
| Revenue This Year | $17.25 | N/A |
| Revenue Next Year | $17.23 | N/A |
| P/E Ratio | $95.48 | ★ N/A |
| Revenue Growth | ★ 7.26 | N/A |
| 52 Week Low | $1.26 | $5.70 |
| 52 Week High | $4.08 | $18.00 |
Technical Indicators
Market Signals| Indicator | OPAL | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 39.28 | 50.67 |
| Support Level | $2.28 | $6.92 |
| Resistance Level | $2.38 | $7.60 |
| Average True Range (ATR) | 0.18 | 0.45 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 7.86 | 62.26 |
Price Performance
Historical ComparisonAbout OPAL OPAL Fuels Inc.
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.